XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Stock award plan - (Tables)
9 Months Ended
Sep. 30, 2023
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2022

 

11,502,417

$

43.33

 

  

 

  

Granted

 

1,059,054

$

41.29

 

  

 

  

Exercised

 

(806,407)

$

29.48

 

  

 

  

Forfeited/Cancelled

 

(318,281)

$

47.84

 

  

 

  

Outstanding at September 30, 2023

 

11,436,783

$

43.99

 

5.87

years

$

5,084

Vested or Expected to vest at September 30, 2023

 

2,357,250

$

46.72

 

8.23

years

$

Exercisable at September 30, 2023

 

8,533,144

$

43.18

 

5.05

years

$

5,084

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Nine months ended

    

September 30, 2023

Risk-free interest rate

 

3.54% - 3.91%

Expected volatility

 

53% - 54%

Expected term

 

5.5 years

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2022

2,516,336

$

45.67

Granted

 

1,973,973

40.00

Vested

 

(778,442)

46.34

Forfeited

 

(297,765)

42.65

Unvested at September 30, 2023

 

3,414,102

$

42.50

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

Research and development

$

13,986

$

15,063

$

44,828

$

41,896

Selling, general and administrative

 

12,956

 

13,607

 

40,300

 

41,093

Total

$

26,942

$

28,670

$

85,128

$

82,989